AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Clorox reported Q1 FY26 earnings that beat estimates but decreased YoY. Net sales fell 19%, and organic sales dropped 17% due to lower volumes from ERP transition challenges. Shares have lost 21.1% in the past six months, and the company is focused on resilience and adaptability amidst the transition.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet